A Concise review on application of solid lipids and various techniques in the formulation development

  • Sandip Barku Ahire Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India
  • Ravindra Keshavrao Kamble Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India

Abstract

Lipids have wide range of applications in food and pharmaceuticals. The pharmaceuticals application of lipid is to improve solubility of drug also helps to improve the bioavailability. The dissolution/dissolving phase, which is probably the rate-limiting component for oral absorption of poorly water-soluble drugs, is eliminated by pre-dissolving pharmaceuticals in lipids, surfactants, or combinations of lipid excipients and surfactants. The most widely used co-solvents, together with lipid excipients, are propylene glycol, glycerol, and polyethylene glycols-400, poloxamer etc. various technologies are used such as melt extrusion, melt granulation for preparation of lipid based oral modified released dosage forms.  This review summaries the overview of the lipid excipients in terms of their classification, methods of absorption, and lipid-based product development. The manufacture of solid and semi-solid lipid formulations using various methodologies, applications, phase behaviour, and the regulatory outlook of lipid excipients are covered.


Keywords: Solid lipids, lipid classification, solidification techniques, modified released.

Keywords: Solid lipids, lipid classification, solidification techniques, modified released

Downloads

Download data is not yet available.

Author Biographies

Sandip Barku Ahire, Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India

Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India

Ravindra Keshavrao Kamble, Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India

Department of Pharmaceutics, Faculty of Pharmacy, Bhupal Nobles’ University, Old Station Road, Udaipur- 313001. Rajasthan, India

References

1) Stuchlík M, Zak S. Lipid-based vehicle for oral drug delivery. Biomedical Papers-Palacky University in Olomouc. 2001 Dec 1; 145(2):17-26. https://doi.org/10.5507/bp.2001.008
2) Stegemann S, Leveiller F, Franchi D, De Jong H, Lindén H. When poor solubility becomes an issue: from early stage to proof of concept. European journal of pharmaceutical sciences. 2007 Aug 1; 31(5):249-61. https://doi.org/10.1016/j.ejps.2007.05.110
3) Chakraborty S, Shukla D, Mishra B, Singh S. Lipid-an emerging platform for oral delivery of drugs with poor bioavailability. European journal of pharmaceutics and biopharmaceutics. 2009 Sep 1; 73(1):1-5. https://doi.org/10.1016/j.ejpb.2009.06.001
4) Drewe JU, Meier RE, Vonderscher JA, Kiss DE, Posanski UL, Kissel T, Gyr K. Enhancement of the oral absorption of cyclosporin in man. British journal of clinical pharmacology. 1992 Jul; 34(1):60-4. https://doi.org/10.1111/j.1365-2125.1992.tb04108.x
5) Kovarik JM, Mueller EA, Kutz K, Van Bree JB, Tetzloff W. Reduced inter-and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. Journal of pharmaceutical sciences. 1994 Mar 1; 83(3):444-6. https://doi.org/10.1002/jps.2600830336
6) Odeberg JM, Kaufmann P, Kroon KG, Höglund P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. European journal of pharmaceutical sciences. 2003 Dec 1; 20(4-5):375-82. https://doi.org/10.1016/j.ejps.2003.08.005
7) Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Advanced drug delivery reviews. 2001 Aug 23; 50(1-2):61-80. https://doi.org/10.1016/S0169-409X(01)00151-X
8) Prabhu S, Ortega M, Ma C. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. International journal of pharmaceutics. 2005 Sep 14; 301(1-2):209-16. https://doi.org/10.1016/j.ijpharm.2005.05.032
9) Kim JW, Ulrich J. Prediction of degree of deformation and crystallization time of molten droplets in pastillation process. International journal of pharmaceutics. 2003 May 12; 257(1-2):205-15. https://doi.org/10.1016/S0378-5173(03)00141-8
10) Zurao P, Landge S, Jaiswal S, Chandewar A. Lipids-The instrumental excipient in pharmaceutical dosages form. International Journal of Research in Pharmacy and Chemistry. 2011; 1(4):992-7.
11) Gülmezoğlu E, Yıldız Türkyılmaz G, Karasulu HY. Preparation and Evaluation of a Lipid-Based Drug Delivery System to Improve Valsartan Oral Bioavailability: Pharmacokinetic and Pharmacodynamic Analysis. Drug Development and Industrial Pharmacy. 2022 Dec 30(just-accepted):1-5. https://doi.org/10.1080/03639045.2022.2164588
12) Rosiaux Y, Jannin V, Hughes S, Marchaud D. Solid lipid excipients-Matrix agents for sustained drug delivery. Journal of Controlled Release. 2014 Aug 28; 188:18-30. https://doi.org/10.1016/j.jconrel.2014.06.004
13) Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems-an overview. Acta Pharmaceutica Sinica B. 2013 Dec 1; 3(6):361-72. https://doi.org/10.1016/j.apsb.2013.10.001
14) Zaro JL. Lipid-based drug carriers for prodrugs to enhance drug delivery. The AAPS journal. 2015 Jan; 17:83-92. https://doi.org/10.1208/s12248-014-9670-z
15) Garrigue JS, Lambert G, Benita S. Self-emulsifying oral lipidbased formulations for improved delivery of lipophilic drugs. Microencapsulation: Methods and Industrial Applications. 2006; 2:429-80. https://doi.org/10.1201/9781420027990.pt3
16) Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2009; 26(6). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i6.10
17) Pardeshi C, Rajput P, Belgamwar V, Tekade A, Patil G, Chaudhary K, Sonje A. Solid lipid based nanocarriers: An overview/Nanonosači na bazi čvrstih lipida: Pregled. Acta pharmaceutica. 2012; 62(4):433-72. https://doi.org/10.2478/v10007-012-0040-z
18) Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal. 2021 Sep 1; 29(9):999-1012. https://doi.org/10.1016/j.jsps.2021.07.015
19) Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022 Feb 17; 27(4):1372. https://doi.org/10.3390/molecules27041372
20) Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K, Rosenholm JM. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018 Oct 18; 10(4):191. https://doi.org/10.3390/pharmaceutics10040191
21) Konermann L, Pan J, Liu YH. Hydrogen exchange mass spectrometry for studying protein structure and dynamics. Chemical Society Reviews. 2011; 40(3):1224-34. https://doi.org/10.1039/C0CS00113A
22) Siram K, Rahman SH, Balakumar K, Duganath N, Chandrasekar R, Hariprasad R. Pharmaceutical nanotechnology: brief perspective on lipid drug delivery and its current scenario. In Biomedical applications of nanoparticles 2019 Jan 1 (pp. 91-115). William Andrew Publishing. https://doi.org/10.1016/B978-0-12-816506-5.00005-X
23) Becker K, Salar-Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharmaceutical Research. 2015 May; 32:1519-45. https://doi.org/10.1007/s11095-015-1661-y
24) Kim JW, Ulrich J. Prediction of degree of deformation and crystallization time of molten droplets in pastillation process. Int J Pharm. 2003 May 12; 257(1-2):205-15. PMID: 12711175. https://doi.org/10.1016/S0378-5173(03)00141-8
25) Bashiri-Shahroodi A, Nassab PR, Szabó-Révész P, Rajkó R. Preparation of a solid dispersion by a dropping methodto improve the rate of dissolution of meloxicam. Drug development and industrial pharmacy. 2008 Jan 1; 34(7):781-8. https://doi.org/10.1080/03639040801925735
26) Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets. Drug Development and Industrial Pharmacy. 2013 Aug 1; 39(8):1167-74. https://doi.org/10.3109/03639045.2012.681053
27) Rosiaux Y, Jannin V, Hughes S, Marchaud D. Solid lipid excipients-Matrix agents for sustained drug delivery. Journal of Controlled Release. 2014 Aug 28; 188:18-30. https://doi.org/10.1016/j.jconrel.2014.06.004
28) Jamzad S. Analysis and application of bio-erodible swelling polymers in the development of controlled-release matrix systems for low-dose BCS class 2 drugs, using glipizide as a model drug. Temple University; 2006.
29) Wang B, Sun X, Xiang J, Guo X, Cheng Z, Liu W, Tan S. A critical review on granulation of pharmaceuticals and excipients: Principle, analysis and typical applications. Powder Technology. 2022 Mar 30:117329. https://doi.org/10.1016/j.powtec.2022.117329
30) Dash TR, Verma P. Matrix tablets: an approach towards oral extended release drug delivery. International Journal of Pharma Research & Review. 2013 Feb; 2(2):12-24.
31) Kowalski J, Kalb O, Joshi YM, Serajuddin AT. Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product. International journal of pharmaceutics. 2009 Oct 20; 381(1):56-61. https://doi.org/10.1016/j.ijpharm.2009.05.043
32) Sirisha VR, Sri KV, Suresh K, Reddy GK, Devanna N. A review of pellets and pelletization process-A multiparticulate drug delivery system. International Journal of Pharmaceutical Sciences and Research. 2013 Jun 1; 4(6):2145.
33) Bose S, Bogner RH. Solventless pharmaceutical coating processes: a review. Pharmaceutical development and technology. 2007 Jan 1; 12(2):115-31. https://doi.org/10.1080/10837450701212479
34) Damian F, Harati M, Schwartzenhauer J, Van Cauwenberghe O, Wettig SD. Challenges of dissolution methods development for soft gelatin capsules. Pharmaceutics. 2021 Feb 4; 13(2):214. https://doi.org/10.3390/pharmaceutics13020214
35) Tran PH, Tran TT, Park JB, Lee BJ. Controlled release systems containing solid dispersions: strategies and mechanisms. Pharmaceutical research. 2011 Oct; 28:2353-78. https://doi.org/10.1007/s11095-011-0449-y
36) Vasanthavada M, Serajuddin AT. Lipid-based self-emulsifying solid dispersions. InOral Lipid-Based Formulations 2007 Jun 8 (pp. 171-206). CRC Press. https://doi.org/10.3109/9781420017267-10
37) Osmałek T, Froelich A, Jadach B, Tatarek A, Gadziński P, Falana A, et al. Recent Advances in Polymer-Based Vaginal Drug Delivery Systems. Pharmaceutics [Internet] 2021; 13(6):884. https://doi.org/10.3390/pharmaceutics13060884
38) Freire Petrovick G. Orodispersible Tablets Containing Taste-Masked Lipid Pellets with Metformin Hydrochloride for Use by Elderly Patients (Doctoral dissertation, Düsseldorf, Heinrich-Heine-Universität, Diss., 2015).
39) Jannin V, Cuppok Y. Hot-melt coating with lipid excipients. International journal of pharmaceutics. 2013 Dec 5; 457(2):480-7. https://doi.org/10.1016/j.ijpharm.2012.10.026
40) Zaid Alkilani A, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015 Oct 22; 7(4):438-70. https://doi.org/10.3390/pharmaceutics7040438
41) Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharmaceutical research. 2013 Dec; 30:2993-3017. https://doi.org/10.1007/s11095-013-1107-3
42) Kolbina M. Phospholipids as functional excipients in solid oral dosage forms. Freie Universitaet Berlin (Germany); 2018.
43) Steward PA, Hearn J, Wilkinson MC. An overview of polymer latex film formation and properties. Advances in colloid and interface science. 2000 Jul 28; 86(3):195-267. https://doi.org/10.1016/S0001-8686(99)00037-8
44) Kreye F, Siepmann F, Siepmann J. Drug release mechanisms of compressed lipid implants. International journal of pharmaceutics. 2011 Feb 14; 404(1-2):27-35. https://doi.org/10.1016/j.ijpharm.2010.10.048
45) Güres S, Siepmann F, Siepmann J, Kleinebudde P. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments. European journal of pharmaceutics and biopharmaceutics. 2012 Jan 1; 80(1):122-9. https://doi.org/10.1016/j.ejpb.2011.10.002
46) Guse C, Koennings S, Kreye F, Siepmann F, Göpferich A, Siepmann J. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. International journal of pharmaceutics. 2006 May 18; 314(2):137-44. https://doi.org/10.1016/j.ijpharm.2005.08.030
47) Rosiaux Y, Jannin V, Hughes S, Marchaud D. Solid lipid excipients-Matrix agents for sustained drug delivery. Journal of Controlled Release. 2014 Aug 28; 188:18-30. https://doi.org/10.1016/j.jconrel.2014.06.004
48) Schulze S, Winter G. Lipid extrudates as novel sustained release systems for pharmaceutical proteins. Journal of Controlled Release. 2009 Mar 19; 134(3):177-85. https://doi.org/10.1016/j.jconrel.2008.11.026
49) Treanor G, Roberts M, Mostafa S, Miolane C. Diluent Effects on Drug Release from Sustained-Release Compritol (R) 888 ATO Tablets. InJournal of Pharmacy and Pharmacology 2010 Oct 1 (Vol. 62, No. 10, pp. 1419-1420).
50) Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. European Journal of Pharmaceutics and Biopharmaceutics. 2001 Sep 1; 52(2):181-90. https://doi.org/10.1016/S0939-6411(01)00162-X
51) El-Shanawany S. Sustained release of nitrofurantoin from inert wax matrixes. Journal of controlled release. 1993 Jul 1; 26(1):11-9. https://doi.org/10.1016/0168-3659(93)90204-I
52) Herrmann S, Winter G, Mohl S, Siepmann F, Siepmann J. Mechanisms controlling protein release from lipidic implants: effects of PEG addition. Journal of controlled release. 2007 Apr 2; 118(2):161-8. https://doi.org/10.1016/j.jconrel.2006.11.001
53) Sax GL. Twin-screw extruded lipid implants for controlled drug delivery (Doctoral dissertation, lmu).
54) Jannin V, Pochard E, Chambin O. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol® ATO 5. International journal of pharmaceutics. 2006 Feb 17; 309(1-2):6-15. https://doi.org/10.1016/j.ijpharm.2005.10.042
55) Mohl S, Winter G. Continuous release of rh-interferon α-2a from triglyceride matrices. Journal of controlled release. 2004 May 31; 97(1):67-78. https://doi.org/10.1016/j.jconrel.2004.02.027
56) Güres S, Kleinebudde P. Dissolution from solid lipid extrudates containing release modifiers. International journal of pharmaceutics. 2011 Jun 30; 412(1-2):77-84. https://doi.org/10.1016/j.ijpharm.2011.04.010
57) Jannin V, Bérard V, Andrès C. Modification of the drug release of ibuprofen by Hot-Melt Coating with mixes of Compritol® 888 ATO and non-ionic surfactants. Tablet. 2005; 80(90):100.
58) Goodhart FW, McCoy RH, Ninger FC. Release of a water-soluble drug from a wax matrix timed-release tablet. Journal of Pharmaceutical sciences. 1974 Nov 1; 63(11):1748-51. https://doi.org/10.1002/jps.2600631117
59) Schwartz JB, Simonelli AP, Higuchi WI. Drug Release from Wax Matrices II: Application of a Mixture Theory to the Sulfanilamide-Wax System. Journal of Pharmaceutical Sciences. 1968 Feb 1; 57(2):278-82. https://doi.org/10.1002/jps.2600570207
60) Ratsimbazafy V, Bourret E, Brossard C. Influence of the manufacturing process on the release of proxyphylline from lipid matrices. Pharmazie. 1997; 52(11):863-6.
61) Özyazıcı M, Gökçe EH, Ertan G. Release and diffusional modeling of metronidazole lipid matrices. European journal of pharmaceutics and biopharmaceutics. 2006 Jul 1; 63(3):331-9. https://doi.org/10.1016/j.ejpb.2006.02.005
62) Kreye F, Siepmann F, Siepmann J. Drug release mechanisms of compressed lipid implants. International journal of pharmaceutics. 2011 Feb 14; 404(1-2):27-35. https://doi.org/10.1016/j.ijpharm.2010.10.048
Crossmark
Statistics
218 Views | 69 Downloads
How to Cite
1.
Ahire SB, Kamble RK. A Concise review on application of solid lipids and various techniques in the formulation development. JDDT [Internet]. 15May2023 [cited 18May2024];13(5):87-. Available from: https://jddtonline.info/index.php/jddt/article/view/5817